PAM
Paradigm Asset Management Portfolio holdings
AUM
$405M
1-Year Return
15.78%
This Quarter Return
+8.59%
1 Year Return
+15.78%
3 Year Return
+47.15%
5 Year Return
+99.02%
10 Year Return
+216.38%
AUM
$356M
AUM Growth
+$56.4M
(+19%)
Cap. Flow
+$19.5M
Cap. Flow
% of AUM
5.46%
Top 10 Holdings %
Top 10 Hldgs %
14.42%
Holding
550
New
79
Increased
181
Reduced
93
Closed
43
Top Buys
| 1 |
Microsoft
MSFT
|
$7.07M |
| 2 |
Johnson & Johnson
JNJ
|
$4.17M |
| 3 |
CVS Health
CVS
|
$4M |
| 4 |
Chevron
CVX
|
$3.52M |
| 5 |
Apple
AAPL
|
$3.43M |
Top Sells
| 1 |
Devon Energy
DVN
|
$9.13M |
| 2 |
Applied Materials
AMAT
|
$3.75M |
| 3 |
Bristol-Myers Squibb
BMY
|
$3.69M |
| 4 |
Cigna
CI
|
$3.26M |
| 5 |
NOV
NOV
|
$3.06M |
Sector Composition
| 1 | Financials | 13.14% |
| 2 | Healthcare | 10.72% |
| 3 | Technology | 8.72% |
| 4 | Industrials | 7.54% |
| 5 | Energy | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Mid-America Apartment Communities
MAA
$17B
| $62.5K | 0.02% |
398
-5,600
| -93% | -$879K |
|
252
Salesforce
CRM
$239B
| $59.7K | 0.02% |
450
-6,700
| -94% | -$888K |
|
|
BF
253
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
| $58.6K | 0.02% |
4,763
| – | – |
|
254
Amcor
AMCR
$19.1B
| $58.4K | 0.02% |
4,900
| – | – |
|
255
DexCom
DXCM
$31.6B
| $57.1K | 0.02% |
504
-7,500
| -94% | -$849K |
|
|
AXA
256
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $55.7K | 0.02% |
2,000
| – | – |
|
257
Prudential
PUK
$33.7B
| $52.2K | 0.01% |
1,900
| – | – |
|
258
SAP
SAP
$313B
| $51.6K | 0.01% |
500
| – | – |
|
259
Sumitomo Mitsui Financial
SMFG
$105B
| $50.5K | 0.01% |
6,300
| – | – |
|
260
Lear
LEA
$5.91B
| $50.5K | 0.01% |
407
-5,950
| -94% | -$738K |
|
261
Beazer Homes USA
BZH
$781M
| $47K | 0.01% |
3,680
| – | – |
|
262
Celanese
CE
$5.34B
| $42.4K | 0.01% |
415
-5,800
| -93% | -$593K |
|
|
PARA
263
DELISTED
Paramount Global Class B
PARA
| $42.2K | 0.01% |
2,500
-35,550
| -93% | -$600K |
|
264
Mitsubishi UFJ Financial
MUFG
$174B
| $39.4K | 0.01% |
5,900
| – | – |
|
265
Takeda Pharmaceutical
TAK
$48.6B
| $39K | 0.01% |
2,500
| – | – |
|
266
Charles River Laboratories
CRL
$8.07B
| $38.4K | 0.01% |
176
-2,600
| -94% | -$567K |
|
267
Avantor
AVTR
$9.07B
| $38.2K | 0.01% |
1,811
-27,400
| -94% | -$578K |
|
|
CS
268
DELISTED
Credit Suisse Group
CS
| $38K | 0.01% |
12,484
| – | – |
|
269
ING
ING
$71B
| $37.7K | 0.01% |
3,100
| – | – |
|
270
Diageo
DEO
$61.3B
| $35.6K | 0.01% |
200
| – | – |
|
271
GSK
GSK
$81.5B
| $35.1K | 0.01% |
1,000
| – | – |
|
272
HDFC Bank
HDB
$361B
| $34.2K | 0.01% |
500
| – | – |
|
273
CarMax
KMX
$9.11B
| $30.1K | 0.01% |
495
-7,200
| -94% | -$438K |
|
274
Ryanair
RYAAY
$32.1B
| $29.9K | 0.01% |
1,000
| – | – |
|
|
AKZOY
275
DELISTED
AKZO NOBEL N V ADR
AKZOY
| $29K | 0.01% |
1,300
| – | – |
|